MARGARET B. KINSELLA (M.D.) – Rheumatology Physician, NPI 1962523084
Preparing for Medicare enrollment?
Use our CMS-855 prep checklist: which form applies (855I, 855O, or 855A), readiness score, NPPES field map, and Section 12 documents. Reassignment uses CMS-855I Section 4F—not the discontinued CMS-855R form.
Open Medicare 855 Prep tool →Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
Provider Addresses for MARGARET B. KINSELLA (M.D.)
470 BIRCHWOOD AVE STE C
SUITE C
BELLINGHAM, WA 982251781
Phone: (360) 734-5754
Type: Mailing
470 BIRCHWOOD AVE
SUITE C
BELLINGHAM, WA 982251781
Phone: (360) 676-1610
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 56 Open Payments records for all available years, with a total value of $1,153.
Total Amount is formed as General ($1,153) + Research ($0) + Ownership ($0) = $1,153.
Last reported payment date: 2024-06-12 • Largest payer in this snapshot: E.R. Squibb & Sons, L.L.C. ($248).
Total Amount
$1,153
General + Research + Ownership
Payments
56
Total payment records
General Amount
$1,153
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-06-12
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| E.R. Squibb & Sons, L.L.C. | $248 |
| AstraZeneca Pharmaceuticals LP | $191 |
| Amgen Inc. | $164 |
| Janssen Biotech, Inc. | $80 |
| Horizon Therapeutics plc | $46 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
No Medicare enrollment or revalidation data available for this provider in our database.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 40,780 | 11 | $0 |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 30,400 | 26 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,055 | 34 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,650 | 12 | $0 |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,140 | 23 | $0 |
Insurance plans in this area (ZIP 98225)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | WA | 96415 | Infusion of chemotherapy into a vein | 98 | 26 |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.